Moreno Evelyn V reduced its stake in Stryker Corporation (NYSE:SYK) by 5.1% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 61,614 shares of the medical technology company’s stock after selling 3,298 shares during the quarter. Stryker accounts for approximately 2.9% of Moreno Evelyn V’s portfolio, making the stock its 6th largest holding. Moreno Evelyn V’s holdings in Stryker were worth $9,540,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Koch Industries Inc. lifted its holdings in Stryker by 34,120.3% during the second quarter. Koch Industries Inc. now owns 1,260,675 shares of the medical technology company’s stock valued at $1,252,000 after purchasing an additional 1,256,991 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in Stryker by 2,237.8% during the second quarter. Janus Henderson Group PLC now owns 1,019,254 shares of the medical technology company’s stock valued at $141,452,000 after purchasing an additional 975,656 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Stryker by 2.8% during the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after purchasing an additional 657,656 shares during the last quarter. APG Asset Management N.V. lifted its holdings in Stryker by 117.1% during the third quarter. APG Asset Management N.V. now owns 583,736 shares of the medical technology company’s stock valued at $82,902,000 after purchasing an additional 314,800 shares during the last quarter. Finally, Pictet Asset Management Ltd. lifted its holdings in Stryker by 25.4% during the third quarter. Pictet Asset Management Ltd. now owns 1,286,239 shares of the medical technology company’s stock valued at $182,672,000 after purchasing an additional 260,502 shares during the last quarter. 74.85% of the stock is currently owned by institutional investors.

Several research firms have commented on SYK. Oppenheimer reaffirmed a “hold” rating and set a $165.00 price objective on shares of Stryker in a report on Thursday, February 1st. Citigroup reaffirmed a “market perform” rating and set a $165.00 price objective (up from $156.00) on shares of Stryker in a report on Thursday, February 1st. They noted that the move was a valuation call. Guggenheim reaffirmed a “buy” rating on shares of Stryker in a report on Wednesday, January 31st. Piper Jaffray Companies reiterated a “buy” rating and set a $170.00 price target on shares of Stryker in a research report on Wednesday, January 31st. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $163.00 price target on shares of Stryker in a research report on Tuesday, January 30th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the company’s stock. Stryker has an average rating of “Hold” and a consensus target price of $162.50.

Stryker Corporation (NYSE SYK) opened at $148.01 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.29 and a quick ratio of 1.59. The firm has a market cap of $57,509.09, a P/E ratio of 23.68, a P/E/G ratio of 2.21 and a beta of 0.70. Stryker Corporation has a 52-week low of $122.28 and a 52-week high of $170.00.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.95 by $0.01. The company had revenue of $3.47 billion for the quarter, compared to analysts’ expectations of $3.42 billion. Stryker had a net margin of 8.20% and a return on equity of 24.55%. Stryker’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.78 earnings per share. analysts anticipate that Stryker Corporation will post 7.12 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be given a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 1.27%. The ex-dividend date is Wednesday, March 28th. Stryker’s dividend payout ratio (DPR) is 70.15%.

In other Stryker news, insider Graham A. Mclean sold 2,984 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $160.53, for a total value of $479,021.52. Following the completion of the sale, the insider now owns 9,100 shares of the company’s stock, valued at $1,460,823. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP William E. Berry, Jr. sold 1,306 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $164.42, for a total value of $214,732.52. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 16,840 shares of company stock worth $2,749,989. 7.40% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: This article was posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.watchlistnews.com/moreno-evelyn-v-has-9-54-million-position-in-stryker-corporation-syk/1855513.html.

Stryker Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.